0001127602-24-006253.txt : 20240222
0001127602-24-006253.hdr.sgml : 20240222
20240222150542
ACCESSION NUMBER: 0001127602-24-006253
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240221
FILED AS OF DATE: 20240222
DATE AS OF CHANGE: 20240222
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: EISENBERG GLENN A
CENTRAL INDEX KEY: 0001222831
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-11353
FILM NUMBER: 24664305
MAIL ADDRESS:
STREET 1: P O BOX 1017
CITY: CHARLOTTE
STATE: NC
ZIP: 28201-1017
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: LABORATORY CORP OF AMERICA HOLDINGS
CENTRAL INDEX KEY: 0000920148
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 133757370
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 358 S MAIN ST
CITY: BURLINGTON
STATE: NC
ZIP: 27215
BUSINESS PHONE: 3362291127
MAIL ADDRESS:
STREET 1: 358 S MAIN ST
CITY: BURLINGTON
STATE: NC
ZIP: 27215
FORMER COMPANY:
FORMER CONFORMED NAME: NATIONAL HEALTH LABORATORIES HOLDINGS INC
DATE OF NAME CHANGE: 19940314
4
1
form4.xml
PRIMARY DOCUMENT
X0508
4
2024-02-21
0000920148
LABORATORY CORP OF AMERICA HOLDINGS
LH
0001222831
EISENBERG GLENN A
531 SOUTH SPRING STREET
BURLINGTON
NC
27215
1
Chief Financial Officer, EVP
0
Common Stock
2024-02-21
4
M
0
14054
163.63
A
58099
D
Common Stock
2024-02-21
4
S
0
18379
215.3661
D
39720
D
Common Stock
2024-02-21
4
S
0
7907
215.6759
D
31813
D
Common Stock
2024-02-21
4
S
0
6665
217.5205
D
25148
D
Common Stock
2024-02-21
4
S
0
1553
217.9842
D
23595
D
Non-qualified Stock Options
163.63
2024-02-21
4
M
0
14054
0
D
2021-02-04
2030-02-03
Common Stock
14054
0
D
The price of $215.3661 per share represents a weighted average of sales prices ranging from $214.80 to $215.79 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security
holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.
The price of $215.6759 per share represents a weighted average of sales prices ranging from $215.80 to $216.66 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security
holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.
The price of $217.5205 per share represents a weighted average of sales prices ranging from $216.87 to $217.86 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security
holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.
The price of $217.9842 per share represents a weighted average of sales prices ranging from $217.89 to $218.075 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security
holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.
Employee stock option (right to buy) granted pursuant to the Laboratory Corporation of America Holdings 2016 Omnibus Incentive Plan.
Represents amounts automatically adjusted based on the final adjustment ratio applied to equity awards in connection with the spin-off of Fortrea Holdings Inc. ("Fortrea") by Laboratory Corporation of America Holdings ("Labcorp"), calculated pursuant to the terms of the Employee Matters Agreement by and between Labcorp and Fortrea.
The option vested in three equal annual installments beginning on the date reflected in this column.
/s/ Sandra D. van der Vaart, Attorney-in-Fact for Glenn A. Eisenberg
2024-02-22